{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T21:02:04Z","timestamp":1776114124147,"version":"3.50.1"},"reference-count":74,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,12,22]],"date-time":"2022-12-22T00:00:00Z","timestamp":1671667200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>The increasing ageing population has led to an increase in the prevalence of neurodegenerative diseases, such as Alzheimer\u2019s disease (AD), Parkinson\u2019s disease (PD), and amyotrophic lateral sclerosis (ALS). However, as yet, there are no simple biomarkers to predict the onset of such diseases. Recently, VGF and its peptides have been highlighted in neurodegenerative diseases. VGF (non-acronymic) is a polypeptide induced in PC12 cells by neurotrophic factors.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective<\/jats:title><jats:p>This systematic review aimed to determine whether VGF and\/or its derived peptides can be used as biomarkers for the diagnosis of ALS, PD, and AD with specific attention to (1) the levels of VGF and\/or its derived peptides, (2) amyloid-beta, (3) dopamine, and (4) cognitive score.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methodology<\/jats:title><jats:p>A search was undertaken in the Ovid EMBASE, Cochrane Library, PubMed, Scopus, and Web of Science for observational studies. Publications that assessed the level of VGF and\/or its derived peptides among people with neurodegenerative diseases and compared them with healthy people were included. The quality of the included studies was assessed using the National Heart, Lung, and Blood Institute Quality Assessment Tool.<\/jats:p><\/jats:sec><jats:sec><jats:title>Result<\/jats:title><jats:p>A search of the databases yielded 834 studies, of which, eight observational studies met the inclusion criteria with a total of 673 participants (51.7% males) aged &amp;gt;18 years. Seven studies showed significant decreases in VGF and its derived peptides in adults with AD, PD, and ALS compared to healthy controls (<jats:italic>p<\/jats:italic>&amp;lt;0.05). However, one study showed that there was no significant difference in VGF in AD compared to healthy control(<jats:italic>p<\/jats:italic>&amp;gt;0.05). Furthermore, only one study reported that VGF levels were positively correlated with those of tissue dopamine but not with A\u03b21-42, and low levels of VGF were associated to cognitive deficits.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The use of VGF and its derivatives for the diagnosis of PD, ALS, AD remains unclear, so further investigation of the role of VGF in neurodegenerative diseases and pathophysiology is needed to provide new insights.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2022.1032192","type":"journal-article","created":{"date-parts":[[2022,12,22]],"date-time":"2022-12-22T12:52:53Z","timestamp":1671713573000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Could VGF and\/or its derived peptide act as biomarkers for the diagnosis of neurodegenerative diseases: A systematic review"],"prefix":"10.3389","volume":"13","author":[{"given":"Saleha","family":"Alqarni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mashael","family":"Alsebai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,12,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-2667(20)30190-0","article-title":"The burden of neurological diseases in Europe: An analysis for the global burden of disease study 2017","volume":"5","author":"Deuschl","year":"2020","journal-title":"Lancet Public Health"},{"key":"B2","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/539179a","article-title":"Neurodegenerative diseases","volume":"539","author":"Heemels","year":"2016","journal-title":"Nature"},{"key":"B3","unstructured":"How has life expectancy changed over time? - office for national statistics2015"},{"key":"B4","unstructured":"Life expectancy in Scotland 2017-2019 | national records of Scotland2020"},{"key":"B5","unstructured":"Overview of the UK population - office for national statistics2017"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1159\/000495813","article-title":"Ageing population: A neurological challenge","volume":"52","author":"B\u00e9jot","year":"2019","journal-title":"Neuroepidemiology"},{"key":"B7","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1177\/0269881113495118","article-title":"The size, burden and cost of disorders of the brain in the UK","volume":"27","author":"Fineberg","year":"2013","journal-title":"J Psychopharmacol Oxf Engl"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1126\/science.3839317","article-title":"Molecular cloning of a gene sequence regulated by nerve growth factor","volume":"229","author":"Levi","year":"1985","journal-title":"Science"},{"key":"B9","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1128\/mcb.9.1.135","article-title":"Nerve growth factor regulates gene expression by several distinct mechanisms","volume":"9","author":"Cho","year":"1989","journal-title":"Mol Cell Biol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.1128\/mcb.11.5.2335","article-title":"Structure of the gene encoding VGF, a nervous system-specific MRNA that is rapidly and selectively induced by nerve growth factor in PC12 cells","volume":"11","author":"Salton","year":"1991","journal-title":"Mol Cell Biol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.23-34-10800.2003","article-title":"Brain-derived neurotrophic factor-induced gene expression reveals novel actions of VGF in hippocampal synaptic plasticity","volume":"23","author":"Alder","year":"2003","journal-title":"J Neurosci"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1210\/en.2007-0038","article-title":"VGF-derived peptide, TLQP-21, regulates food intake and body weight in Siberian hamsters","volume":"148","author":"Jethwa","year":"2007","journal-title":"Endocrinology"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/S0896-6273(00)80806-5","article-title":"Targeted deletion of the vgf gene indicates that the encoded secretory peptide precursor plays a novel role in the regulation of energy balance","volume":"23","author":"Hahm","year":"1999","journal-title":"Neuron"},{"key":"B14","article-title":"In Situ Hybridization: MRNA Levels of Secretogranin II, VGF and Peptidylglycine Alpha-Amidating Monooxygenase in Brain of Salt-Loaded Rats","volume-title":"Histochemistry","author":"Mahata","year":"1993"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2015.00003","article-title":"Neuroendocrine role for VGF","volume":"6","author":"Lewis","year":"2015","journal-title":"Front Endocrinol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1159\/000127319","article-title":"Role of VGF-derived peptides in the control of food intake, body weight and reproduction","volume":"88","author":"Jethwa","year":"2008","journal-title":"Neuroendocrinology"},{"key":"B17","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/S0306-4522(97)00280-7","article-title":"The messenger RNA encoding VGF, a neuronal peptide precursor, is rapidly regulated in the rat central nervous system by neuronal activity, seizure and lesion","volume":"82","author":"Snyder","year":"1997","journal-title":"Neuroscience"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2010.11","article-title":"The expression of VGF is reduced in leukocytes of depressed patients and it is restored by effective antidepressant treatment","volume":"35","author":"Cattaneo","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-4159.1997.68041390.x","article-title":"Molecular cloning and characterization of the human VGF promoter region","volume":"68","author":"Canu","year":"1997","journal-title":"J Neurochemistry"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0606102103","article-title":"TLQP-21, a VGF-derived peptide, increases energy expenditure and prevents the early phase of diet-induced obesity","volume":"103","author":"Bartolomucci","year":"2006","journal-title":"Proc Natl Acad Sci United States America"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2005.05.015","article-title":"Pro-VGF-Derived peptides induce penile erection in Male rats: Involvement of paraventricular nitric oxide","volume":"49","author":"Succu","year":"2005","journal-title":"Neuropharmacology"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-4159.2002.00842.x","article-title":"Isolation and characterization of VGF peptides in rat brain. role of PC1\/3 and PC2 in the maturation of VGF precursor","volume":"81","author":"Trani","year":"2002","journal-title":"J Neurochemistry"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1023\/B:CEMN.0000023627.79947.22","article-title":"Processing, distribution, and function of VGF, a neuronal and endocrine peptide precursor","volume":"24","author":"Levi","year":"2004","journal-title":"Cell Mol Neurobiol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-009-8796-0","article-title":"\u2018Neuroendocrine regulatory peptide-1 and -2: Novel bioactive peptides processed from VGF\u2019","volume":"66","author":"Toshinai","year":"2009","journal-title":"Cell Mol Life Sciences\u202f: CMLS"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M701665200","article-title":"Peptidomic identification and biological validation of neuroendocrine regulatory peptide-1 and -2\u2019","volume":"282","author":"Yamaguchi","year":"2007","journal-title":"J Biol Chem"},{"key":"B26","doi-asserted-by":"publisher","first-page":"(3)","DOI":"10.1152\/ajpendo.00768.2009","article-title":"\u2018Neuroendocrine regulatory peptide-2 regulates feeding behavior via the orexin system in the hypothalamus\u2019","volume":"299","author":"Toshinai","year":"2010","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0164689","article-title":"VGF protein and its c-terminal derived peptides in amyotrophic lateral sclerosis: Human and animal model studies","volume":"11","author":"Brancia","year":"2016","journal-title":"PloS One"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.2007.04666.x","article-title":"Hippocampal gene expression profiling reveals the possible involvement of Homer1 and GABAB receptors in scopolamine-induced amnesia","volume":"102","author":"Brouillette","year":"2007","journal-title":"J Neurochemistry"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.3145-08.2008","article-title":"The neurotrophin-inducible gene vgf regulates hippocampal function and behavior through a brain-derived neurotrophic factor-dependent mechanism","volume":"28","author":"Bozdagi","year":"2008","journal-title":"J Neurosci"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2008.10.006","article-title":"\u2018Neuropeptides in depression: Role of VGF\u2019","volume":"197","author":"Thakker-Varia","year":"2009","journal-title":"Behav Brain Res"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-7580.2010.01309.x","article-title":"Distribution of VGF peptides in the human cortex and their selective changes in parkinson\u2019s and alzheimer\u2019s diseases","volume":"217","author":"Cocco","year":"2010","journal-title":"J Anat"},{"key":"B32","doi-asserted-by":"publisher","first-page":"170444","DOI":"10.1016\/j.peptides.2020.170444","article-title":"Evaluation of VGF peptides as potential anti-obesity candidates in pre-clinical animal models","volume":"136","author":"Dalb\u00f8ge","year":"2021","journal-title":"Peptides"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.2007.05068.x","article-title":"TLQP-21, a neuroendocrine VGF-derived peptide, prevents cerebellar granule cells death induced by serum and potassium deprivation","volume":"104","author":"Severini","year":"2008","journal-title":"J Neurochemistry"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2020.01.111","article-title":"TLQP-21 mediated activation of microglial BV2 cells promotes clearance of extracellular fibril amyloid-\u03b2","volume":"524","author":"Cho","year":"2020","journal-title":"Biochem Biophys Res Commun"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1038\/nm1669","article-title":"Antidepressant actions of the exercise-regulated gene VGF","volume":"13","author":"Hunsberger","year":"2007","journal-title":"Nat Med"},{"key":"B36","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1007\/s11064-019-02725-4","article-title":"Neuropeptide VGF-derived peptide LQEQ-19 has neuroprotective effects in an In vitro model of amyotrophic lateral sclerosis","volume":"44","author":"Noda","year":"2019","journal-title":"Neurochemical Res"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.scr.2014.03.005","article-title":"\u2018VGF (TLQP-62)-Induced neurogenesis targets early phase neural progenitor cells in the adult hippocampus and requires glutamate and BDNF signaling\u2019","volume":"12","author":"Thakker-Varia","year":"2014","journal-title":"Stem Cell Res"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.1127-09.2009","article-title":"Proteomic analysis uncovers novel actions of the neurosecretory protein VGF in nociceptive processing","volume":"29","author":"Riedl","year":"2009","journal-title":"J Neurosci"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1021\/pr501076j","article-title":"An integrated workflow for multiplex CSF proteomics and peptidomics-identification of candidate cerebrospinal fluid biomarkers of alzheimer\u2019s disease","volume":"14","author":"H\u00f6ltt\u00e4","year":"2015","journal-title":"J Proteome Res"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1002\/prca.201700131","article-title":"A parallel reaction monitoring mass spectrometric method for analysis of potential CSF biomarkers for alzheimer\u2019s disease","volume":"12","author":"Brinkmalm","year":"2018","journal-title":"Proteomics. Clin Appl"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1002\/pmic.200300470","article-title":"A panel of cerebrospinal fluid potential biomarkers for the diagnosis of alzheimer\u2019s disease","volume":"3","author":"Carrette","year":"2003","journal-title":"Proteomics"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000203129.82104.07","article-title":"Identification of potential CSF biomarkers in ALS","volume":"66","author":"Pasinetti","year":"2006","journal-title":"Neurology"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2005.08.002","article-title":"Identification of CSF biomarkers for frontotemporal dementia using SELDI-TOF","volume":"196","author":"R\u00fcetschi","year":"2005","journal-title":"Exp Neurol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymeth.2012.03.018","article-title":"\u2018A novel peptidomics approach to detect markers of alzheimer\u2019s disease in cerebrospinal fluid\u2019","volume":"56","author":"Wijte","year":"2012","journal-title":"Methods (San Diego Calif.)"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.7150\/ijms.5.92","article-title":"Vgf is a novel biomarker associated with muscle weakness in amyotrophic lateral sclerosis (ALS), with a potential role in disease pathogenesis","volume":"5","author":"Zhao","year":"2008","journal-title":"Int J Med Sci"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"B47","unstructured":"Study quality assessment tools2014"},{"key":"B48","doi-asserted-by":"publisher","first-page":"(1)","DOI":"10.1186\/s13195-019-0537-5","article-title":"\u2018VGF peptides in cerebrospinal fluid of patients with dementia with lewy bodies\u2019","volume":"11","author":"Van Steenoven","year":"2019","journal-title":"Alzheimer\u2019s Res Ther"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1097\/WAD.0000000000000328","article-title":"VGF in cerebrospinal fluid combined with conventional biomarkers enhances prediction of conversion from MCI to AD","volume":"33","author":"Llano","year":"2019","journal-title":"Alzheimer Dis Associated Disord"},{"key":"B50","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s00441-019-03128-1","article-title":"VGF peptides as novel biomarkers in parkinson\u2019s disease","volume":"379","author":"Cocco","year":"2020","journal-title":"Cell Tissue Res"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1038\/nature20411","article-title":"Ageing, neurodegeneration and brain rejuvenation","volume":"539","author":"Wyss-Coray","year":"2016","journal-title":"Nature"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1007\/BF00966824","article-title":"Ventricular injection of nerve growth factor increases dopamine content in the striata of MPTP-treated mice","volume":"17","author":"Garcia","year":"1992","journal-title":"Neurochemical Res"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchemneu.2011.05.007","article-title":"VGF: An inducible gene product, precursor of a diverse array of neuro-endocrine peptides and tissue-specific disease biomarkers","volume":"42","author":"Ferri","year":"2011","journal-title":"J Chem Neuroanat"},{"key":"B54","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.mce.2013.03.012","article-title":"\u2018Continuous stress promotes expression of VGF in melanotroph via suppression of dopamine\u2019","volume":"372","author":"Tokizane","year":"2013","journal-title":"Mol Cell Endocrinol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.12-07-02573.1992","article-title":"NGF induces the expression of the VGF gene through a CAMP response element","volume":"12","author":"Hawley","year":"1992","journal-title":"J Neurosci"},{"key":"B56","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/s41467-020-17405-z","article-title":"Multiscale causal networks identify VGF as a key regulator of alzheimer\u2019s disease","volume":"11","author":"Beckmann","year":"2020","journal-title":"Nat Commun"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.0584-15.2015","article-title":"VGF and its c-terminal peptide TLQP-62 regulate memory formation in hippocampus via a BDNF-TrkB-Dependent mechanism","volume":"35","author":"Lin","year":"2015","journal-title":"J Neurosci"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/j.str.2014.10.001","article-title":"The TLQP-21 peptide activates the G-Protein-Coupled receptor C3aR1 via a folding-upon-Binding mechanism","volume":"22","author":"Cero","year":"2014","journal-title":"Structure"},{"key":"B59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13024-020-0357-x","article-title":"VGF-derived peptide TLQP-21 modulates microglial function through C3aR1 signaling pathways and reduces neuropathology in 5xFAD mice","volume":"15","author":"El Gaamouch","year":"2020","journal-title":"Mol Neurodegeneration"},{"key":"B60","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1146\/annurev.neuro.24.1.677","article-title":"Neurotrophins: Roles in neuronal development and function","volume":"24","author":"Huang","year":"2001","journal-title":"Annu Rev Neurosci"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.3389\/neuro.02.001.2010","article-title":"A simple role for BDNF in learning and memory","volume":"3","author":"Cunha","year":"2010","journal-title":"Front Mol Neurosci"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1016\/0896-6273(91)90273-3","article-title":"BDNF MRNA is decreased in the hippocampus of individuals with alzheimer\u2019s disease","volume":"7","author":"Phillips","year":"1991"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2005.01.026","article-title":"Decreased levels of BDNF protein in Alzheimer temporal cortex are independent of BDNF polymorphisms","volume":"194","author":"Lee","year":"2005","journal-title":"Exp Neurol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.2005.03135.x","article-title":"Precursor form of brain-derived neurotrophic factor and mature brain-derived neurotrophic factor are decreased in the pre-clinical stages of alzheimer\u2019s disease","volume":"93","author":"Peng","year":"2005","journal-title":"J Neurochemistry"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2009.54","article-title":"Brain-derived neurotrophic factor in neurodegenerative diseases","volume":"5","author":"Zuccato","year":"2009","journal-title":"Nat Rev Neurol"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1111\/j.1601-183X.2010.00676.x","article-title":"BDNF-restricted knockout mice as an animal model for aggression","volume":"10","author":"Ito","year":"2011","journal-title":"Genes Brain Behav"},{"key":"B67","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.jalz.2013.05.1765","article-title":"Reduced 25-hydroxyvitamin d and risk of alzheimer\u2019s disease and vascular dementia","volume":"10","author":"Afzal","year":"2014","journal-title":"Alzheimer\u2019s Dementia"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000000755","article-title":"Vitamin d and the risk of dementia and Alzheimer disease","volume":"83","author":"Littlejohns","year":"2014","journal-title":"Neurology"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1002\/mds.25405","article-title":"The relationship between balance control and vitamin d in parkinson\u2019s disease-a pilot study","volume":"28","author":"Peterson","year":"2013","journal-title":"Movement Disord"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1404477111","article-title":"Vitamin d prevents cognitive decline and enhances hippocampal synaptic function in aging rats","volume":"111","author":"Latimer","year":"2014","journal-title":"Proc Natl Acad Sci"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1530\/JME-15-0224","article-title":"Thyroid hormone and vitamin d regulate VGF expression and promoter activity","volume":"56","author":"Lewis","year":"2016","journal-title":"J Mol Endocrinol"},{"key":"B72","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1523\/JNEUROSCI.21-01-00098.2001","article-title":"Vitamin d hormone confers neuroprotection in parallel with downregulation of l-type calcium channel expression in hippocampal neurons","volume":"21","author":"Brewer","year":"2001","journal-title":"J Neurosci"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchemneu.2004.07.003","article-title":"Effects of 1\u03b1,25 dihydroxyvitamin d 3 on the expression of HO-1 and GFAP in glial cells of the photothrombotically lesioned cerebral cortex","volume":"28","author":"Oermann","year":"2004","journal-title":"J Chem Neuroanat"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1016\/S0197-0186(98)00075-8","article-title":"Vitamin d receptor in SH-SY5Y human neuroblastoma cells and effect of 1,25-dihydroxyvitamin D3 on cellular proliferation","volume":"34","author":"Celli","year":"1999","journal-title":"Neurochemistry Int"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.1032192\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,22]],"date-time":"2022-12-22T12:52:56Z","timestamp":1671713576000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.1032192\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,22]]},"references-count":74,"alternative-id":["10.3389\/fendo.2022.1032192"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2022.1032192","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,22]]},"article-number":"1032192"}}